panretin
eisai gmbh - alitretinoin - sarcoma, kaposi - antineoplastična sredstva - panretin gel je navedena za lokalno zdravljenje kožne lezije pri bolnikih s pridobljenim-imunski-pomanjkljivosti-sindrom (aids), povezanih z kaposi ' s sarkom (ks), če:so poškodbe, ki niso ulcerated ali lymphoedematous, in;zdravljenje globokih ks, ni potrebno, in;poškodbe se ne odziva na sistemski antiretrovirusne terapije, in;naprave za radioterapijo ali kemoterapijo niso primerne.
xigris
eli lilly nederland b.v. - drotrekogin alfa (aktiviran) - sepsis; multiple organ failure - antitrombotična sredstva - zdravilo xigris je indicirano za zdravljenje odraslih bolnikov s hudo sepso z večkratnim odpovedovanjem organov, kadar so dodani najboljši standardni oskrbi. uporaba zdravila xigris je treba obravnavati predvsem v primerih, ko se zdravljenje lahko začne 24 ur po začetku odpovedi organa (za nadaljnje informacije glejte poglavje 5.
treprostinil amomed 1 mg/ml raztopina za infundiranje
treprostinil - raztopina za infundiranje - treprostinil 1 mg / 1 ml - treprostinil
treprostinil amomed 10 mg/ml raztopina za infundiranje
treprostinil - raztopina za infundiranje - treprostinil 10 mg / 1 ml - treprostinil
treprostinil amomed 2,5 mg/ml raztopina za infundiranje
treprostinil - raztopina za infundiranje - treprostinil 2,5 mg / 1 ml - treprostinil
treprostinil amomed 5 mg/ml raztopina za infundiranje
treprostinil - raztopina za infundiranje - treprostinil 5 mg / 1 ml - treprostinil
utrogestan 200 mg mehke vaginalne kapsule
progesteron - vaginalna kapsula, mehka - progesteron 200 mg / 1 kapsula - progesteron
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - neoplazme dojke - antineoplastična sredstva - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
utrogestan 300 mg mehke vaginalne kapsule
progesteron - vaginalna kapsula, mehka - progesteron 300 mg / 1 kapsula - progesteron
katalip 160 mg filmsko obložene tablete
fenofibrat - filmsko obložena tableta - fenofibrat 160 mg / 1 tableta - fenofibrat